The company attributed an estimated $135 million in lost sales to June’s NotPetya cyberattack, which temporarily led Merck to halt drug production. Remediation costs related to the cyberattack also contributed to the company’s $2.4 billion in marketing and administrative expenses, a similar expense to the $2.39 billion Merk reported during the third quarter of 2016.
The worldwide cyberattack NotPetya infected computer systems in more than 60 countries June 27. Merck was the first major U.S. company to acknowledge NotPetya had compromised its computer network, which it confirmed via Twitter June 27.
More articles on supply chain:
7 drug, devicemakers in the headlines
Is Amazon also looking to enter the medical device business?
FDA hires Mylan exec as senior communications adviser
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
